Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.01
Delayed Data
As of May 27
 -0.09 / -2.20%
Today’s Change
3.26
Today|||52-Week Range
6.59
+15.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues12.8M8.2M9.2M12.3M
 
 
 
 
 
Cost of Goods Sold851.5K667.0K1.4M1.1M
 
 
 
 
 
Depreciation And Amortization2.3M2.3M2.3M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income9.6M5.2M5.4M8.7M
 
 
 
 
 
General Expenses35.0M31.4M35.6M30.4M
 
 
 
 
 
Research And Development27.0M24.5M27.8M22.0M
 
 
 
 
 
Total Operating Expenses38.2M34.4M39.4M34.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.4M-26.2M-30.2M-21.7M
 
 
 
 
 
Extraordinary Credit1.0M2.6M929.0K0.00
 
 
 
 
Extraordinary Charge0.00-----1.5M
 
 
Interest Expense On Debt1.7M1.7M1.7M1.7M
 
 
 
 
 
Other Expenses33.6M14.7M-1.1M660.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.5M-10.7M-32.1M-24.3M
 
 
 
 
 
Net Income7.5M-10.7M-32.1M-24.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS219.7M219.9M220.2M235.7M
 
 
 
 
 
Shares To Calculate EPS Diluted225.3M219.9M220.2M235.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.03-$0.05-$0.15-$0.10
 
 
 
 
 
EPS Diluted$0.03-$0.05-$0.15-$0.10
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account